Developing New Schiff Base Complexes with Pyridine Moiety as Anticancer Agents | Chapter 7 | Novel Aspects on Chemistry and Biochemistry Vol. 4

 This stage investigated to expand New Schiff Base Complexes with Pyridine Moiety as Anticancer Agents. Cancer can result from unusual proliferation of one the different types of cells in the body, so skilled are more than a hundred different types of cancer, that can vary substantially in their nature and response to situation. The most important issue in tumor pathology is the distinction 'tween benign and diseased tumors. This study searched the anticancer studies of pyridine Schiff group of chemical elements complexes from 2015 to 2021. Information was gathered from the picked studies to analyze and focal point the importance of anticancer powers. A total of sixty six full-length articles on the subject were checked, the results were summarized, and the action against different container types was given as IC50 values or hindrance percentages. On the critical amount, we found that compared to Schiff base ligand, the alloy complexes shown excellent endeavor towards various cancer container lines (including MCF-7, HeLa, HCT-116, Hepa-2). This episode discovered that the ore complexes were more potent than the Schiff base ligands. We decide that this article will aid investigators in developing new Schiff base composites with pyridine moiety as anticancer powers.

Author(s) Details:

R. Induleka,

Department of Chemistry, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, Tamil Nadu-641043, India.

M. Gowri,

Department of Chemistry, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, Tamil Nadu-641043, India.

Please see the link here: https://stm.bookpi.org/NACB-V4/article/view/11258

Role of Pyridine Containing Azetidinone Derivatives as Privileged Scaffolds in Anti Tubercular Agents | Chapter 9 | Technological Innovation in Pharmaceutical Research Vol. 11

In the current study, we synthesised a novel series of 3-Chloro-1-phenyl-4-(pyridine-4yl-)azetidin-2-one derivatives using Schiff base as an intermediary in the quest for prospective Tuberculosis treatments. The resulting Schiff base is then eliminated, resulting in named Azetidinone derivatives. Nucleophilic addition followed by elimination is the mechanism involved in the production of Schiff base. The newly produced Schiff base is then cyclized to produce novel Azetedinone derivatives. The named compounds were physically examined and structurally investigated using spectroscopic methods (IR, 1H-NMR, MASS). The chemicals Azt-1 to Azt-6 were tested for anti-tubercular activity in vitro. The Micro plate Alamar Blue Assay (MABA) method was used to test anti-tubercular activity in vitro. Azt-1(H), Azt-2(Cl), Azt-5 (O-OH), and Azt-6 (P-OH) were the most active compounds in the series compared to standards. The presence of electron withdrawing group -Cl, (Azt-2) and electron donating substituents -OH at ortho and para positions in the phenyl ring of (Azt-5) and (Azt-6) respectively could explain the potent anti tubercular activity.

Author (S) Details

N. Pramod
Department of Pharmaceutical Chemistry, A.G.M College of Pharmacy, Varur-581207, Hubli, Karnataka, India.

C. Bharath Kumar
Department of Pharmaceutical Chemistry, Annamacharya College of Pharmacy, Rajampet-516126, Kadapa, Andhra Pradesh, India.

P. Sri Lekha
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Technology, SPMVV, Tirupati-517502, Andhra Pradesh, India.

B. Mayuri
Department of Pharmaceutical Chemistry, Annamacharya College of Pharmacy, Rajampet-516126, Kadapa, Andhra Pradesh, India.

View Book :- https://stm.bookpi.org/TIPR-V11/article/view/3131